I. Introduction
T HE GnRH neurons represent the final output component of a neuronal network that integrates multiple environmental and internal factors to regulate reproductive hormone secretion. The episodic release of GnRH into the hypophyseal portal system from nerve terminals located in the median eminence creates a pulsatile pattern of LH secretion (1, 2) . Fluctuations in this pattern of GnRH release, combined with alterations in the secretory capacity of the pituitary gonadotrophs, generate the marked changes in LH secretion profile observed over the course of the ovarian cycle (3, 4) . Most dramatically, the midcycle LH surge, which is responsible for initiating ovulation, is now known to result from an abrupt and massive increase in hypophyseal portal GnRH secretion in a number of mammalian species (5-10).
Estrogen is one of the principal determinants of GnRH neuron functioning and, acting as a classic homeostatic feedback molecule between gonad and brain, is critical in enabling these cells to exhibit fluctuating patterns of biosynthetic and secretory activity. For the greater part of the ovarian cycle, estrogen helps restrain LH secretion through what has been termed its "negative feedback" action. This has been shown to occur, in part, through an inhibition of GnRH secretion in several species (7, 11-13), but also involves potent actions of estrogen on the pituitary gonadotrophs (3, 4, 14) . Estrogen also exhibits a "positive feedback" influence upon the GnRH neurons and pituitary gonadotrophs to generate the preovulatory LH surge. Whereas the rising follicular phase concentrations of circulating estradiol are sufficient on their own to generate the GnRH surge in some spontaneously ovulating species (8, 10, 15), others, such as the rat, require the rising levels of estrogen to coincide with a circadian input to trigger the surge (11, 16, 17) . Together, these observations indicate an important, indeed critical, influence of estrogen upon the functioning of mammalian GnRH neurons.
The purpose of this review is to provide an account of the effects of estrogen upon the GnRH neuron and describe how this may come about. The latter issue is not simple as these cells are not thought to express classic nuclear estrogen receptors (ERs) (see below). It is important at the outset to state the intended limitations of the review. First, it focuses entirely upon the female and the cyclical patterns of GnRH neuronal activity encountered in the reproductively active adult. Data from rodent, ovine, and nonhuman primate species are considered. Second, although it is recognized that estrogen exerts important physiological actions at the level of the pituitary gland (4, 5, 14), the present review focuses specifically upon the central mechanisms of estrogen action. To this end, GnRH secretion data have been sought and used extensively but, where unavailable, inference has been taken with due care from LH measurements. Third, because of the importance and potential similarities in estrogen's influence upon the GnRH neuron across species, the review does not deal with progesterone actions. The one exception will be in regard to the rat where, as in the human (18), progesterone has a role in the generation of the normal shape of the estrogen-induced LH surge (19). This influence is entirely dependent upon estrogen preexposure (20) and, where possible and appropriate, the interactions between estrogen and progesterone are highlighted in the rat.
Finally, a definition. The "GnRH pulse generator" and "GnRH surge generator" are phrases that were used extensively in the past to refer to the ill-defined neural elements responsible for the pulsatile and surge patterns of GnRH secretion, respectively. While such constructs are helpful in a conceptual sense, they are difficult in that they imply the unproven hypothesis that specific "pulse" and "surge" GnRH neuronal systems exist. Hence, for the purposes of this review, I will refer to the "GnRH network." This is defined as "the GnRH neurons, the glial cells directly associated with them, and the non-GnRH neuronal populations involved in regulating the activity of GnRH neurons." Using these definitions and focus, I intend to 1) provide a catalog of the effects of estrogen on the GnRH neuron, 2) highlight three different modes of estrogen action within the GnRH network, and 3) propose a simple framework model for how estrogen may engender cyclical activity upon the GnRH neurons.
II. Effects of Estrogen on GnRH Neurons

A. Sexual differentiation
Sex differences in mammalian brain structure and functioning are believed to result from developmental "organizational" and adult "activational" influences of gonadal steroids (21, 22). Both mechanisms appear to be operative in terms of the GnRH network. The clearest such sex difference is seen in the rat and sheep where embryonic and/or perinatal testosterone secretion renders the male of the species unable to generate an LH surge after puberty (23-26). This sex difference in LH secretion arises from the sexual differentiation of GnRH secretion as the pituitary is not involved (27-30). Direct evidence of the absence of a GnRH surge in the male has been provided recently by Herbosa and colleagues (31) in the sheep. In the rat, this masculinization is known to be engendered by estrogen after aromatization of testosterone in the brain (32, 33). Interestingly, there is no evidence for an organizational influence of testosterone on the ability of the GnRH network to exhibit a surge in the monkey (28, 34). Instead, as estradiol administration to a gonadectomized, but not intact, adult male monkey evokes an LH surge equivalent to that of the female, it appears that a testicular factor exerts an "activational" inhibitory influence upon the GnRH network (35, 36) . Testosterone exposure during primate development does, nevertheless, engender sex differences involving estrogen's inhibitory effects on LH secretion (28), and a similar phenomenon is encountered in the sheep (37, 38).
The precise developmental period during which estrogen, derived from testosterone, exerts its "organizational" influence upon the GnRH network varies among species. In the rat, this so-called "critical period" for masculinization of the GnRH network is near the time of birth. Testosterone or estrogen administered to female rats on single or multiple days over the first 5 postnatal days will render them unable to generate an LH surge after puberty (23, 26, 32) whereas the gonadectomy of male rats must occur within a few hours of birth if they are to exhibit female-like LH surges as adults (26, 39) . In the sheep, the critical period for testosterone exposure is relatively prolonged and occurs between gestational days 30 -100 with masculinization of the LH surge mechanism observed in females exposed to testosterone between gestational days 30 and 80 or between days 50 and 100 but not for shorter periods such as embryonic days 30 -51 or 65-86 (25, 38).
The site and mechanism of estrogen's influence remain uncertain. Sex differences do not exist in the number, distribution, or morphology of GnRH neurons in the rat and sheep (40 -42). They have, however, been found in the synaptic innervation pattern of GnRH neurons (43), the immediate early gene transcriptional response of GnRH neurons to estradiol (44), and the expression of galanin by a subpopulation of GnRH neurons (45, 46) . Although some of these observations implicate sex differences in the nonGnRH components of the network, their identity remains elusive (47-49).
B. Biosynthesis of GnRH
Available evidence suggests that the transcription rate, mRNA stability, and posttranslational processing of GnRH are all actively regulated in native GnRH neurons (50). With respect to the effects of estrogen on GnRH biosynthesis, most attention has focused upon GnRH mRNA expression, and several investigators have examined the influence of the estrous cycle, ovariectomy, and estrogen replacement on transcript levels in the female rat (reviewed in Refs. 50 and 51). Unfortunately, the result of these studies has been one of widespread disagreement as to whether estrogen has any influence on GnRH mRNA expression and if so, whether this may be inhibitory or stimulatory in nature (see tables in Refs. 50 and 51). However, recent work from the laboratory of Petersen and co-workers (52, 53) has cleared much of this confusion by showing that estrogen's influence on GnRH mRNA expression is dependent upon the time of day as well as the precise location of the GnRH neurons within the medial septal-preoptic-hypothalamic continuum. In essence, it appears that estrogen exerts a stimulatory influence on GnRH mRNA expression in only rostral preoptic area neurons and that a gradual increase in GnRH mRNA content, from the low levels found in the morning in estrogen-treated rats, results in a peak of expression in the early afternoon before the onset of the LH surge (Fig. 1) . As GnRH mRNA expression in ovariectomized rats remains relatively stable, at an intermediate level between that of morning and afternoon levels in estradiol-treated rats (Fig. 1) , the evaluation of estrogen-treated rats killed in the morning (54, 55), when estrogen is exerting an inhibitory influence on LH secretion, seems likely to have been responsible for the reported inhibitory effects of estrogen on GnRH mRNA content (53). Thus, estrogen at low levels appears to inhibit GnRH mRNA expression relative to ovariectomized rats while estrogen at higher concentrations and in association with a circadian mechanism enhances GnRH mRNA levels ( Fig. 1) .
A reevaluation of GnRH mRNA data in this light provides a good level of agreement between studies that have examined rostral preoptic area GnRH mRNA expression on the afternoon of the steroid-induced or proestrous LH surge (53, 56 -63). The only major discrepancy remaining is that of the temporal relationship between the increase in mRNA content and the onset of the LH surge. An increase in rostral preoptic area cellular or tissue GnRH mRNA expression is found to occur either hours before the increase in LH release (53, 56, 62-64) or coincident with the onset of the LH surge (59, 62). Of particular note, the study by Porkka-Heiskanen and col- June, 1998 ESTROGEN INPUTS TO GnRH NEURONS 303 leagues (62) demonstrated that GnRH mRNA expression at the level of the organum vasculosum of the lamina terminalis increased at the time of the surge while content in more caudal sections increased much earlier in the afternoon. This may suggest the existence of subpopulations of GnRH neurons within the rostral preoptic area in terms of their pattern of GnRH gene transcription at the time of the surge. This observation is reminiscent of GnRH immunocytochemical data which indicate that preoptic GnRH neurons positioned laterally and caudally in the preoptic area respond differently to more midline GnRH neurons in the face of changing gonadal steroid concentrations (65, 66). Information on the estrogen regulation of GnRH mRNA in species other than the rat is very limited. Recent studies in the sheep suggest that cellular GnRH mRNA content does not increase in association with the GnRH surge (67, 68). This may represent an important species difference and, perhaps, reflect the absence of any substantial circadian influence upon the timing of the GnRH surge in this species. In terms of estrogen's inhibitory influence upon GnRH transcript levels, a recent study suggests that estrogen may also repress GnRH mRNA expression in the human as postmenopausal females were found to exhibit significantly higher levels of cellular GnRH mRNA compared with premenopausal women, and this was argued to be independent of age (69). Our own preliminary work in the mouse also indicates that higher levels of GnRH mRNA expression are found throughout the GnRH population after gonadectomy (70).
Estrogen's stimulatory influence upon GnRH mRNA expression is likely to be exerted principally at the level of GnRH gene transcription. Gore and Roberts (63) reported that an increase in GnRH primary transcript expression occurred early on proestrus, and Petersen and colleagues (64) found that estrogen increased GnRH primary transcript levels in advance of the increase in mature GnRH mRNA before the LH surge. It is less clear whether the inhibitory influence of estrogen on GnRH mRNA content may also be exerted at a transcriptional level. Two recent studies that have used GnRH promotor-driven reporters to examine the in vivo transcriptional regulation of the GnRH gene in transgenic mice have found that gonadectomy increases, while estradiol given in a negative feedback manner reduces, reporter expression in the rostral preoptic area (70, 71). While such evidence suggests that estrogen may alter gene transcription to both increase and decrease GnRH mRNA expression, the degree to which changes in GnRH mRNA stability (50) may be involved has not been established.
It is true, however, that the overall level of GnRH mRNA content correlates with mean LH secretion better than it does with circulating estradiol concentrations (Fig. 1) . This suggests that a simple linear relationship between circulating estradiol concentrations and GnRH mRNA expression is unlikely to exist and that multiple estrogen-receptive and/or other pathways are likely to be involved in regulating GnRH gene transcription and mRNA processing within the cell. For example, as outlined above, there is good evidence in the rat for an interaction between estrogen and circadian inputs on GnRH mRNA expression.
Studies also indicate that estrogen is involved in regulating the posttranslational processing of the pro-GnRH peptide. Ovariectomy has been found to decrease pro-GnRH peptide concentrations either with (57) or without (72) similar changes in GnRH mRNA expression, and estradiol replacement does not alter GnRH mRNA and pro-GnRH peptide levels to the same degree (57). Hence, changes in GnRH mRNA and pro-GnRH peptide contents do not necessarily occur in parallel, and this has led to the idea that estrogen 
C. Biosynthesis of galanin
The only well characterized neuropeptide known to be coexpressed by GnRH neurons is the 29-amino acid neuropeptide galanin (74, 75). Galanin mRNA and peptide are expressed in a sexually dimorphic manner within a subpopulation of GnRH neurons (46, 76), and this depends upon both organizational actions of testosterone during the perinatal period (45, 46) and activational effects of estradiol in the adult female rat (77-81). Work in the Steiner laboratory has shown that adult ovariectomy results in a decrease in galanin mRNA expression by GnRH neurons, and that this can be restored to intact levels by estrogen replacement (77). Also, the galanin mRNA content of GnRH neurons is maximal on the afternoon of proestrus (77) and, again, this has been shown to result principally from a stimulatory action of circulating estradiol (81). Although it is notable that workers in that laboratory have never found concomitant changes in GnRH mRNA expression, their reports of changing profiles of galanin mRNA content within GnRH neurons have striking similarities with the changes in cellular GnRH mRNA expression found by others (above). In particular, it seems that estrogen may exert a stimulatory influence on the GnRH cell content of both galanin and GnRH transcripts at the time of the estrogen-induced LH surge. One difference is that the galanin mRNA content of GnRH neurons remains elevated for more than 24 h (82) while GnRH transcript numbers, possibly under the influence of progesterone, fall shortly after the surge (53, 63). Whether this stimulatory action of estrogen results from the transcriptional regulation of the galanin gene, as it does for GnRH (63, 64), is not known. Although a good correlation has been shown repeatedly between GnRH "activation" and galanin mRNA expression within GnRH neurons, the physiological significance of galanin's presence within these cells remains unknown (83).
D. Electrical activity of GnRH neurons
The present inability to make direct electrical recordings from GnRH neurons in any routine manner has resulted in an almost complete absence of any information about the effects of estrogen on GnRH neuronal firing. The single exception has been work from the Kelly laboratory (84, 85) where the immunocytochemical post-identification of recorded neurons in the guinea-pig brain slice preparation has resulted in the demonstration of rapid hyperpolarizing actions of 100 nm concentrations of estradiol on the membrane excitability of small numbers of GnRH neurons. As these effects were observed in the presence of tetrodotoxin, which blocks sodium channels and thus synaptic connectivity, estrogen is likely to be acting directly upon the GnRH neuron to reduce its level of electrical activity.
The "electrical" activity of GnRH neurons has also been assessed indirectly by examining expression patterns of immediate early genes such as c-fos and c-jun. Although not expressed by GnRH neurons under all circumstances of increased GnRH secretion, the presence of Fos protein within GnRH neurons is, in general, indicative of neuronal activation (86). Studies in the rat (86), mouse (87), and sheep (88), but curiously not the primate (89), have shown that many of the GnRH cells located within the rostral preoptic area and anterior hypothalamus express Fos at the time of the LH surge. In terms of understanding the estrogen inputs to the GnRH neurons, these observations are useful in that, like the GnRH mRNA studies, they define the rostral preoptic GnRH neurons of the rat as being particularly important in the generation of the GnRH/LH surge. Furthermore, independent studies in the rat have shown that, at the time of the surge, Fos is preferentially induced in GnRH neurons that receive likely circadian inputs (90) and express a relatively high GnRH mRNA content (91). Although estradiol replacement alone enables Fos to be expressed by GnRH neurons coincident with the LH surge, it is apparent that progesterone also plays a role as it enables the further recruitment of GnRH neurons to express Fos as the LH surge progresses in the rat (86). Together, the results of the Fos-GnRH studies are consistent with a stimulatory action of estrogen upon the GnRH cell bodies and suggest that estrogen and circadian inputs may converge to elevate cellular GnRH mRNA content in neurons of the rostral preoptic area in the rat. Although it is tempting to speculate that some of estrogen's effects on GnRH or galanin gene transcription within the GnRH neuron are transduced by immediate early genes, their role(s) within these cells are unknown.
Another means of indirect assessment of GnRH neuron electrical activity has been the use of multiunit recording techniques to examine synchronized electrical discharges in the mediobasal hypothalamus (92, 93). Although these studies have been very successful in providing a good correlation between episodic bursts of multiunit activity and pulsatile LH secretion in a variety of species, the unknown origin of the electrical activity has made it difficult to interpret the absence of an increase in multiunit activity at the time of the LH surge (94, 95) and the estrogen-dependent changes in the size, shape, and occurrence of the multiunit volleys (96 -98). An unanswered question of substantial importance to these studies is whether the multiunit activity results from action potentials in a subset, all, or none of the GnRH axons. There is now good evidence for GnRH receptor expression in the mediobasal hypothalamus of the rat (99), and GnRH is an extremely potent neurotransmitter in this area (100). Further, the infusion of GnRH into the mediobasal hypothalamus of the rat evokes multiunit activity (101). Hence, it is possible that multiunit activity reflects the postsynaptic activation of mediobasal hypothalamic neurons by GnRH collateral innervation. If so, this would represent one explanation for the excellent correlation of multiunit activity and pulsatile LH secretion in the ovariectomized animal, while the estrogeninduced changes in multiunit activity might better reflect the known gonadal steroid-dependent alterations in GnRH receptor expression by mediobasal hypothalamic neurons (99).
E. GnRH secretion
Stimulatory influence of estrogen
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to describe the effects of estrogen on GnRH secretion into the hypophyseal portal system. There is wide agreement across species that estrogen exerts a powerful stimulatory influence on GnRH secreted from nerve terminals in the median eminence to initiate the LH surge (5-9, 15, 102-104). To date, the best characterization of this estrogenenhanced GnRH secretion exists in the ewe (10) where the sampling of portal blood on a minute-by-minute basis has been undertaken. Using this system, Evans and colleagues (104, 105) have demonstrated that the first change from the strictly episodic pattern of GnRH secretion observed under estrogen's negative feedback influence begins 15-20 h after estradiol administration when significant nonepisodic interpulse GnRH secretion occurs. This is followed by an increase in GnRH pulse frequency and amplitude and further enhanced interpulse secretion in the 2-to 4-h period before the onset of the ascending phase of the GnRH surge. Hence, these investigators suggest that the stimulatory effects of estrogen occur through a change in the nature of episodic GnRH secretion as well as a gradual increase in nonepisodic GnRH release and that, together, this represents a shift in the basic mode of GnRH neurosecretion (105). Even in this species, however, there remains some controversy as to whether the GnRH surge itself is composed of discrete episodes of GnRH release or an outpouring of nonpulsatile GnRH (10, 103).
Although not analyzed in nearly the same detail, the description of the estrogen-induced GnRH surge in other species shows common basic features. In particular, it is important to note that the GnRH network of rat, sheep, and primate must be exposed to relatively high concentrations of estrogen for a prolonged period of around 15 h to enable a GnRH surge to occur (8, 11, 15) . With respect to this 15-h period, an important recent insight (106) has been that termination of a 14-h estrogen signal before the onset of the LH surge has no effect on the duration or amplitude of the GnRH surge. This confirms further that prolonged estrogen exposure is required to initiate neural events that generate the GnRH surge but also emphasizes that estrogen need not be present at the time of the surge onset for it to occur. In contrast to the sheep and monkey, where estrogen is sufficient on its own to generate a normal GnRH and LH surge, the pituitary gonadotrophs and GnRH network of the rat require the presence of progesterone for the magnitude of the LH surge to resemble that of the proestrous event in the rat (see Ref. 19) . Although the effects of progesterone supplementation on the estrogen-induced GnRH surge have not been established in the rat, indirect evidence such as the progesterone-dependent buildup of GnRH peptide in the median eminence on proestrus, and progesterone's ability to advance the onset of the surge, suggests an effect of the steroid on GnRH secretion (14, 19). As estrogen is required to induce the expression of progesterone receptors, it is possible that estrogen and progesterone may exert synergistic actions upon the same components of the GnRH network immediately before and during the GnRH surge of the rat (20). After the surge, however, progesterone exerts an inhibitory influence on GnRH secretion in the rat (19), as found in other species.
Inhibitory influence of estrogen
Although much progress has been made in terms of describing the stimulatory effect of estrogen on GnRH release, less agreement has resulted from studies examining the inhibitory influence of estrogen. Initial studies in the female monkey reported inconsistent elevations in portal GnRH release after ovariectomy (107, 108) and failed to detect any substantial effect of high concentrations of estradiol on GnRH release in the median eminence/mediobasal hypothalamus (107, 109). More recently, however, a relatively fast (2-3 h) and potent inhibitory action of estrogen on GnRH pulse amplitude was reported in the midpubertal monkey (12). Indirect assays of GnRH release in the monkey have also suggested that part of the inhibitory effect of estrogen on LH arises from an hypothalamic site (110). A similar state exists in the rat, where Levine and Ramirez (111) found no effect of ovariectomy on mediobasal hypothalamic GnRH release whereas Sarkar and Fink (11), who were able to sample portal GnRH secretion, showed that a significant increase in GnRH output occurred in long-term ovariectomized rats and that estradiol rapidly reduced GnRH secretion within 1 h. While detailed investigations of pulsatile GnRH secretion have not been possible in the intact rat, it is worth noting a series of studies by Leipheimer and colleagues (112, 113) in which estradiol was found to be responsible for restraining both LH pulse frequency and amplitude in intact diestrous rats.
More uniform results have been obtained in sheep where estradiol has been shown to exhibit clear inhibitory actions on portal GnRH secretion (7, 8, 13, 104). As also observed in the monkey (12), the inhibitory action of estrogen in the reproductively active sheep results principally from a decrease in GnRH pulse amplitude (13, 104). Few studies have undertaken a detailed time course analysis of how quickly estrogen suppresses GnRH pulse amplitude in the sheep, but published GnRH profiles suggest that it can occur as soon as 2 h after estrogen (7). Although the time interval after gonadectomy may be an important factor (11), it is unclear why the effects of gonadectomy and estrogen replacement have not been consistent within species such as the rat across different laboratories. It may also be relevant to note that the replacement of estradiol to physiological levels was found to suppress pulsatile GnRH secretion in an ovariectomized monkey while supraphysiological bolus injections of estradiol exerted no clear inhibitory action on GnRH (15).
F. GnRH degradation
Although not strictly an effect of estrogen on the GnRH neuron, it is pertinent to note the emerging evidence that estrogen may also regulate the degradation of GnRH upon release from the nerve terminal in the median eminence. Several studies in the rat have reported that the GnRH degradation rate fluctuates over the estrous cycle of the rat and that peptidase activity is likely to be reduced at the time of the proestrous or ovariectomized, steroid-induced LH surge (114 -117 
G. Ultrastructural changes involving GnRH neurons
The GnRH neurons in the rat, sheep, and monkey exhibit a variety of morphological types, are relatively sparsely innervated, and are enveloped by glial cell processes to varying degrees (124 -127). There is a substantial body of evidence that indicates that gonadal steroids exert potent modulatory actions on the innervation patterns and glial cell relationships of hypothalamic neurons (128), and a number of studies have examined the GnRH neurons in this light. In the monkey, Witkin and colleagues (126, 129) have shown that ovariectomy results in a decrease in the percentage of GnRH neurons exhibiting a spiny appearance, an increase in their degree of glial cell envelopment, and a small decrease in their synaptic innervation. Preliminary data from Naftolin and colleagues (130) using a different monkey model indicate, however, that the chronic treatment of monkeys with premarin, an equine estrogen preparation, results in a decrease in the number of synapses on GnRH neurons.
In the rat, where there is less evidence for glial cell wrapping of the GnRH cell bodies, the ovariectomy of reproductively active females was found to have no effect on GnRH glial cell ensheathment or their density of synaptic input (131). At the level of the median eminence, ovariectomy was found to induce fluctuations in the distance between the GnRH terminals and the basal lamina overlying the portal capillaries in the rat (132). Furthermore, the GnRH terminals of the mouse and rat are known to be enveloped by tanycytic end feet (133, 134), and recent work by King and colleagues has suggested that gonadal steroids may modulate the degree of glial cell encasement of the GnRH terminals (134, 135). Hence, ultrastructural rearrangements in glial cell-GnRH terminal and cell body relationships clearly exist after gonadectomy. However, the degree to which they depend upon estrogen itself remains to be established.
H. Summary of estrogen's influence on GnRH cells
Estrogen first impacts upon the GnRH neurons during development when, after aromatization of testosterone, it acts to permanently masculinize species-specific parameters of the GnRH network. In this way, the "organizational" influence of estrogen engenders the response of GnRH neurons to estrogen throughout postnatal life and dictates that the masculinized network will respond differently to the inhibitory influence of estrogen and/or be unable to generate a GnRH surge.
In the adult female, estrogen exerts a stimulatory influence on the biosynthetic and secretory activity of the GnRH neurons. Estrogen regulates GnRH biosynthesis through modifications of gene transcription as well as posttranscriptional processing, and its stimulatory actions on GnRH secretion may involve the generation of a nonepisodic mode of GnRH release. The GnRH surge requires several hours of estrogen preexposure of the GnRH network and, in the rat, the presence of a circadian input. The GnRH neurons located in the rostral preoptic area of the rat appear to be particularly important in terms of estrogen's stimulatory actions. The prolonged period of elevated estrogen exposure before ovulation seems likely to initiate a cascade of neural events that may differentially impact upon GnRH biosynthesis and secretion. These stimulatory effects require the presence of electrical activity in the brain as immediate early gene, galanin, and GnRH mRNA expression in GnRH neurons, as well as GnRH secretion itself, are all blocked by administration of the anesthetic pentobarbital (59, 78, 86).
The inhibitory effects of estrogen on GnRH neurons are more controversial, but evidence is consolidating in several species for an inhibitory influence on GnRH secretion, in particular GnRH pulse amplitude, as well as mRNA expression. Compared with estrogen's stimulatory effects, this inhibitory influence on secretion can occur relatively quickly within 1-2 h and may correlate with the evidence for a direct inhibition of GnRH neuron electrical activity by estrogen in the guinea-pig.
III. Brain Sites of Estrogen Influence on GnRH Neurons
The GnRH neurons do not reside within a discrete brain region but form a dispersed longitudinal array of cells within the medial septum, preoptic area, and hypothalamus. Species differences exist in the caudal limits of this continuum, as most GnRH cells are found in the preoptic area of sheep and rats but significant numbers exist within the basal hypothalamus of primates (127). However, retrograde labeling studies have now shown that GnRH neurons throughout this continuum project to the median eminence in rats, sheep, and monkeys (136 -138).
A. Sites of estrogen's stimulatory action
The anteroventral periventricular nucleus (AVPv) in the rat.
The great majority of lesioning and estradiol implant studies addressing the sites of action of estrogen in regulating LH secretion have been undertaken in the rat. In terms of the LH Lesions of the AVPv, but not neighboring nuclei, result in persistent estrus and the abolition of the estrogen-or estrogen plus progesterone-induced LH surge (141-143). Although not administered specifically into the AVPv, 17␤-estradiol placed in the medial preoptic area is able to generate an LH surge in the rat (144, 145) while similarly positioned implants of an antiestrogen inhibit the estrogen-induced LH surge, as well as the concomitant changes in GnRH mRNA expression (146, 147). The implantation of 17␤-estradiol or estradiol benzoate into the medial basal hypothalamus, amygdala, or hippocampus was not found to elicit a surgelike alteration in LH secretion (144, 145). These measurements in the rat involved LH rather than GnRH, and stimulatory actions of estradiol are well established to occur at the level of the gonadotroph (3, 4, 14) . However, when estradiol concentrations reaching the pituitary gland are carefully controlled (145), the cerebral implantation data clearly supported the concept that the preoptic area was an important brain site through which estradiol likely initiated a GnRH surge in the rat (148).
Not surprisingly, receptor autoradiographic (149), immunocytochemical (150, 151) and mRNA (152) analyses have all demonstrated a very substantial population of ER-containing cells in the preoptic area including the AVPv. The great majority of this work has concentrated on the expression of ER␣ but, after the discovery of a second ER in 1996, termed ER␤ (153, 154), early studies are also suggesting the existence of ER␤ mRNA (155), and to a lesser extent ER␤ protein (156) in the AVPv. Anterograde tracing work shows that a population of AVPv neurons project directly to GnRH neurons (157), and retrograde tracing studies indicate that ER␣-expressing neurons of the AVPv project to the immediate vicinity of the rostral preoptic GnRH neurons (A. E. Herbison and S. X. Simonian, unpublished data). Together, these observations indicate that estrogen-receptive AVPv neurons project directly to the GnRH neurons and raise the possibility that they may mediate the stimulatory actions of estrogen on the electrical and biosynthetic behavior of the GnRH neurons. As ER␣-containing neurons of the AVPv receive direct inputs from the suprachiasmatic nucleus (158), they may also represent a site of integration of circadian and estrogen inputs in the regulation of GnRH neurons.
The neurochemical identity of the estrogen-receptive AVPv neurons has been examined in double-labeling studies, and subpopulations have been reported to express a wide variety of neuropeptides in addition to the inhibitory amino acid ␥-aminobutyric acid (GABA) ( Table 1) . Interestingly, the AVPv is a sexually dimorphic brain region exhibiting more cells in the female than male (159, 160), and this is reflected in the numbers of ER␣-expressing cells found in this area (151, 161, 162). Furthermore, some of the neuropeptide-expressing neuronal populations in the AVPv are sexually dimorphic with greater numbers of ER␣-containing calcitoningene related peptide (163, 164), dynorphin (165, 166), neurotensin (NT) (151), and substance P (162) neurons reported in the female compared with the male. However, precisely which ER␣-containing neurons in the AVPv project to the GnRH neurons remains unknown.
2.
The mediobasal hypothalamus in the ewe. The brain sites responsible for the stimulatory effects of estrogen on GnRH neurons are unknown in the monkey and only beginning to be defined in the sheep. A recent series of studies by Caraty and colleagues (167) in the ewe have demonstrated that 17␤-estradiol-filled cannulae implanted in the mediobasal hypothalamus adjacent to the ER␣-expressing cells of the ventromedial nucleus generate a normal GnRH surge. Estradiol implants within the ER␣-containing cells of the medial preoptic area were unable to elicit a GnRH surge (167). This unexpected finding is in good agreement, however, with previous work in which estradiol implants in the vicinity of the ventromedial nucleus were found to evoke an LH surge in the ewe (168). These observations are surprising as they suggest that a substantial species difference may exist in the brain sites used by estrogen to stimulate GnRH secretion. Earlier studies had suggested that the rat and sheep might not have been different in this respect as many neurons within the periventricular preoptic area of the ewe, which may be the ovine AVPv equivalent, express Fos at the time of the GnRH surge, and some of these neurons contained ERs (88). It will be critical to establish the connectivity of the estrogen-receptive neurons of the ovine ventromedial nucleus and also determine the brain region(s) within the monkey involved in the estrogen-induced GnRH surge.
B. Sites of estrogen's inhibitory action
The brain sites involved in the inhibitory effects of estrogen on GnRH neurons have been difficult to establish. Early (167) have demonstrated that both sites may have a role in the ovine species as 17␤-estradiol implants located in either the medial preoptic area or arcuate nucleus were found to inhibit the amplitude and frequency of pulsatile LH secretion. A further complication in establishing the precise sites of estrogen's inhibitory influence comes from the ability of some brain regions to exhibit an environment-dependent involvement in this process. For example, estrogen administered into the paraventricular nucleus will inhibit LH release in the fasting rat but not in the normal or ovariectomized animal (174). Hence, existing data remain inconclusive and suggest that multiple brain sites and mechanisms may be involved, including the arcuate nucleus and preoptic area. Although this state of progress may be revealing in its own right, this issue is far from resolved. Much less has been done in establishing the brain regions used by estrogen to inhibit GnRH mRNA levels. In hypothalamic slice cultures, estrogen was found to only inhibit GnRH mRNA expression when GnRH neurons existed in close association with the rostral preoptic area (175). In agreement with this observation, Petersen and colleagues demonstrated that the implantation of antiestrogens into the preoptic area blocked estrogen's in vivo inhibitory influence on cellular GnRH mRNA content (147). Hence, the site of estrogen's inhibitory influence upon GnRH biosynthesis may exist within the rostral preoptic area and may be the AVPv itself.
C. Summary
Nothing is known about the sites or mechanisms through which estrogen sexually differentiates the GnRH network during development.
In the adult female rat, there is wide agreement that the AVPv with its many estrogen-receptive neuronal cell populations (Table 1 ) is the critical site at which estrogen acts to bring about its stimulatory effects on GnRH release and biosynthesis. Neurons in the AVPv provide a locus through which estrogen and circadian inputs can be integrated before being transmitted to the GnRH neurons. The brain regions used by estrogen to activate GnRH neurons in other species are less established but may involve the mediobasal hypothalamus, and clear species differences are evident. The brain sites through which estrogen inhibits GnRH secretion are controversial but appear to be different to those used to stimulate GnRH neurons. More than one brain region, including the preoptic area and arcuate nucleus, may be involved. In contrast, available data indicate that the inhibitory effects of estrogen on GnRH mRNA expression may involve the preoptic area in the rat.
An important observation in the mouse (176, 177) and sheep (167) has been that the stimulatory and inhibitory influences of estrogen may occur independently of one another. For example, estradiol implants in the vicinity of the ovine ventromedial nucleus were found to evoke the GnRH/LH surge without showing any evidence of estradiolnegative feedback (167). Combined with evidence for different rates of onset of estrogen's inhibitory and stimulatory actions on GnRH secretion, this suggests that different brain mechanisms may underlie these two phenomenon. Hence, it may be unhelpful to assume, as has previously been the case, that a "switch" from inhibitory to stimulatory feedback occurs. A more useful concept may be to suppose that two potentially independent estrogen-regulated mechanisms exist for restraining and activating GnRH activity (see Section V).
IV. Pathways for Estrogen Regulation of GnRH Neurons
The foregoing account suggests the possibility that at least three fundamentally different types of mechanisms may be used by estrogen to regulate the activity of GnRH neurons (Fig. 2) . The first is that of a direct action of estrogen on GnRH neuron electrical activity, the second an influence of estrogen on other neurons within the GnRH network to regulate GnRH neurons in a transsynaptic fashion, and the third involves changes in glial-GnRH interactions. The following discussion examines each mechanism in terms of its potential contribution to the inhibitory and stimulatory influence of estrogen on GnRH secretion and biosynthesis.
A. Direct regulation of GnRH neurons
1. Genomic regulation. One of the principal findings in GnRH neurobiology has been the observation by Shivers and colleagues (178) that GnRH neurons do not concentrate estradiol. This finding was confirmed using ER␣ double-labeling immunocytochemistry in the rat (151) and extended to the guinea pig (179), mouse (R. S. Slater and A. E. Herbison, unpublished data), sheep (180, 181) and monkey (182, 183). Although the lack of ER immunoreactivity alone is not definitive evidence for the absence of ER␣ in GnRH neurons, when combined with the inability of GnRH neurons to concentrate estradiol, this suggested strongly that estrogen was unlikely to regulate the genome of the GnRH neuron directly in any mammalian species.
The very recent discovery of a second ER, termed ER␤ (153, 154), has reopened the issue as to whether or not GnRH neurons may express an ER. A recent study examining ER␤ mRNA expression in the rat brain (155) has shown that it has a distribution in the rostral preoptic area similar to that of ER␣ mRNA (152). However, an initial immunocytochemical June, 1998 ESTROGEN INPUTS TO GnRH NEURONS 309 study of ER␤ protein distribution in the rat brain found relatively little staining in the preoptic area (156). Furthermore, as the binding affinity of estradiol to ER␤ is very similar to that of ER␣ (184), the original observation by Shivers and colleagues (178) that GnRH neurons do not concentrate [ 3 H]estradiol suggests that they may not express ER␤ either. If so, it would appear that the presence of estrogen response elements within the promotor region of the primate GnRH gene (185) are not relevant in terms of GnRH expression in the brain and that effects of estrogen on GnRH gene transcription do not occur through a classic ER-mediated process. It is relevant to note, however, that a small population of not more than 5% of GnRH neurons in the guinea pig have been shown to express progesterone receptors (186).
The one caveat to these studies and the idea that ERs do not exist in GnRH neurons is that all of the investigations examining this issue have been performed in pubertal (183) or adult animals (151, 179 -182). As noted above, estrogen exerts dramatic and permanent effects on the GnRH network during development, and it remains possible that GnRH neurons express ERs during embryogenesis or early postnatal life and that ER synthesis is abruptly down-regulated with maturation. The one piece of evidence in support of this hypothesis is presence of ERs in immortalized GnRH-secreting cell lines (185, 187), which seem most likely to represent immature GnRH neurons (188, 189).
Nongenomic regulation.
A substantial body of evidence exists in support of rapid, nongenomic actions of estrogen upon neurons located throughout the central nervous system (190, 191) . The effects and mechanisms of estrogen's nongenomic actions appear diverse. Recent work in the hippocampus indicates that nanomolar concentrations of 17␤-estradiol rapidly increase kainate receptor-induced currents by altering the G protein-coupled, cAMP-dependent phosphorylation of potassium channels (192) . Similar concentrations of 17␤-estradiol have also been shown to rapidly alter L-type calcium channels through a putative G-protein coupled mechanism in the neostriatum (193). In both the hippocampus and striatum, many of the effects of 17␤-estradiol can be replicated with 17␤-estradiol conjugated to molecules such as albumin and thus suggest that a membrane estradiol receptor may mediate these effects. Within the hypothalamus, one of the best characterized nongenomic influences of estradiol is that described by where nanomolar concentrations of estradiol rapidly reduce the potency of both -opioid and GABA B receptor agonists on mediobasal hypothalamic neurons. These investigators propose that estrogen may bind to an ER␣-like receptor to activate cAMP-dependent protein kinase which, in turn, uncouples -opioid and GABA B receptors from inwardly rectifying potassium channels (195, 196) .
At present, the only similar data relating to the GnRH neurons is the demonstration of a direct hyperpolarizing influence of nanomolar 17␤-estradiol on GnRH neurons in the ovariectomized guinea pig (85). Unlike other mediobasal hypothalamic neurons in that species, acute estrogen treatment does not alter the response of GnRH neurons to -opioid receptor agonists (85), suggesting that GnRH neurons may not utilize the same estrogen-regulated G protein second messenger system. Clearly, much has yet to be done in determining the full extent of the nongenomic influences of estrogen on GnRH neurons and other neurons within the GnRH network. Estrogen is known to influence several of the enzyme components of the phosphoinositide and adenylase cyclase pathways (reviewed in Ref. 197) , and this may underlie a wide range of possible nongenomic effects of estrogen within this network. It remains to be determined whether similar rapid effects of estrogen on GnRH neurons will occur in other species and whether physiological increments in estrogen concentrations, such as those seen before (198) .
B. Estrogen-receptive neurons as intermediaries
Of all of the potential pathways through which estrogen may regulate the activity of GnRH neurons, that involving ER-containing neurons as intermediaries has received most attention. This has been due, in part, to the difficulty of examining the other possibilities, but also comes from the substantial amount of work indicating that estrogen can act at brain sites remote from the GnRH neurons to influence their activity (Section III). The identification of multiple neurochemically distinct nerve terminals synapsing on GnRH cell bodies (127) combined with the limited evidence for direct presynaptic inputs to GnRH terminals in the median eminence (199, 200) suggests that neurons may act directly at both sites to modulate GnRH secretion. As estrogen-receptive neurons have been identified to project to the immediate vicinity of the GnRH cell bodies in both rat (201) and sheep (A. E. Herbison and A. Caraty, unpublished) as well as the median eminence of the sheep (202) and monkey (203) , it is possible that ER-expressing neuronal populations influence GnRH neurons at both terminal and cell body levels. A very extensive literature exists with regard to the neurochemical regulation of LH and GnRH secretion (204) . However, strong data exist for only a few neurotransmitter pathways in the transsynaptic mediation of estrogen's influence on GnRH neurons. It is clear that an understanding of the estrogen-sensitive AVPv neurons would help greatly in elucidating the nature of estrogen's stimulatory actions on GnRH neurons of the rat. Of the neurotransmitter-containing cell populations identified to express ERs in this area (Table  1) , NT and GABA are presently the most likely candidates for a role in providing estrogen inputs to the GnRH neurons. Data implicating dopaminergic neurons are weak in the rat but strong in the anestrous ewe. Although the estrogen regulation of enkephalin and dynorphin neurons in the AVPv is established, their relationship to the estrogen regulation of GnRH activity is not yet determined (166). Outside of the AVPv there has been a longstanding interest in the role of the brainstem norepinephrine (NE) neurons (see Ref. 201) and substantial investigation into the neuropeptide Y and ␤-endorphin (␤END) populations of the arcuate nucleus (see Ref. 19 ). Finally, although the location of their cell bodies is unknown, glutamate and aspartate cannot be ignored on the basis that they are the most important excitatory neurotransmitters in the brain. A synopsis for each of these neurochemicals in the estrogen-dependent regulation of the GnRH network in adult females is presented below.
Dopamine.
There is little agreement over the role, if any, of dopamine in regulating LH secretion or GnRH activity in the rat (204) . As such, it is impossible to determine with any certainty the role of dopamine in mediating estrogen influences within the GnRH network of this species. This is despite the suggestion that dopaminergic neurons of the AVPv project to GnRH neurons (205) , although these cells do not appear to express ER␣ immunoreactivity in the rat (Table 1) .
This situation is in stark contrast to the sheep where substantial data agree that dopamine plays an important role in mediating estrogen's inhibitory influence on GnRH secretion during anestrus (4, 206, 207) . In the sheep, seasonal changes evoke a marked change in the sensitivity of the GnRH network to estradiol, with maximal estrogen-dependent inhibition exhibited in anestrus (208) . Dopamine D2 receptors are clearly involved in the estrogen-dependent suppression of LH pulse frequency in anestrous ewes (209 -212) , and lesion studies suggest that this involves the A14 and/or A15 dopaminergic cell populations of the anterior hypothalamus (213, 214) . Furthermore, recent investigations have shown that both A14 and A15 cell populations are activated by estrogen during anestrus but not during the breeding season (215, 216) . Although it is known that the season-dependent inhibition of GnRH secretion by dopamine occurs at the level of the median eminence (199, 217, 218) , the relationship of the A14 and A15 dopamine neurons to the relevant dopaminergic terminals in the median eminence remains obscure (216, 219) .
The mechanisms through which estrogen influences the ovine A14/15 dopaminergic neurons to inhibit pulsatile GnRH secretion in a seasonal manner are not yet established.
Although ER␣ immunoreactivity can be demonstrated in the A14, but not A15, dopaminergic neurons, the number of A14 cells expressing ER␣ does not change across season (220) . Furthermore, in contrast to the seasonal changes in tyrosine hydroxylase enzyme activity within the median eminence (218) , no consistent differences in tyrosine hydroxylase mRNA, immunoreactivity, or enzyme activity have been detected in the A14 or A15 cell bodies (218, 220, 221) . The absence of ERs in the A15 dopaminergic neurons and lack of changes in cell body tyrosine hydroxylase activity suggest that estrogen may influence the electrical activity of these cells either through their afferent inputs or in a nongenomic manner. Thus, although it is not known exactly how estradiol influences these dopaminergic neurons to regulate GnRH secretion in anestrous sheep, they remain an interesting illustration of how the GnRH network can recruit specific estrogen-receptive neural components in an environmentally dependent manner.
Excitatory amino acids.
The amino acids glutamate and aspartate are important excitatory neurotransmitters within the neuroendocrine hypothalamus (222) and exert powerful actions on the output of the GnRH network (reviewed in Ref. 223) . Studies employing the pharmacological blockade of the N-methyl-d-aspartate (NMDA), dl-␣-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA), and kainate receptors have shown that glutamate and aspartate play a role in generating both the pulsatile (224) and surge (225) (226) (227) modes of GnRH/LH secretion in the adult female rat. Hence, it seems highly likely that neurons utilizing excitatory amino acids are part of the GnRH network.
However, one of the major problems in trying to understand the excitatory amino acid component of the GnRH
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network is our present inability to identify the location of the glutamatergic cell bodies. As all cells use glutamate for biosynthetic purposes, it is difficult to determine which neurons employ it specifically as a neurotransmitter. This problem is complicated further by the presence of NMDA, AMPA, and kainate receptor subtypes in all of the brain regions implicated in the network (reviewed in Ref. 223) . Only small subpopulations of GnRH neurons in the rat have been reported to express NMDA and/or kainate receptors (228, 229) , and terminals containing glutamate have been demonstrated to synapse on GnRH neurons in the monkey (230) . Neurons throughout the preoptic area and hypothalamus, including the AVPv, have been shown to express all three types of ionotropic excitatory amino acid receptors (223, 231, 232) . Hence, while the phenomenon of excitatory amino acid involvement within the GnRH network is clear, the mechanism of glutamate and aspartate action within the network is likely to be difficult to establish. These restrictions make it difficult to decipher whether or not excitatory amino acids are involved in mediating the inhibitory and/or stimulatory actions of estrogen within the GnRH network. It is quite clear, for example, that the facilitatory effect of NMDA, and AMPA (223), on LH secretion is dependent upon the presence of estrogen in the adult rat, mouse, sheep, and monkey and that it does not involve the pituitary gland (233) (234) (235) (236) . Hence the NMDA and AMPA receptors and/or their related second messenger pathways appear to be "enabled" by estrogen acting in a negative feedback manner on LH secretion. Where these receptors are found, and whether they are actually involved in mediating the inhibitory influence of estrogen within the GnRH network, are unknown. Excitatory amino acid release in the preoptic area and mediobasal hypothalamus is not different in ovariectomized rats and those given estrogen to inhibit LH secretion (237-239). Adding further to this dilemma was the observation that NMDA was equally potent in stimulating GnRH release from mediobasal hypothalamic explants in ovariectomized oil-and estrogen-replaced rats (235) . As studies have not been conducted to determine whether the blockade of excitatory amino acid receptor activity influences estrogen's inhibitory actions on LH, it is not possible, as yet, to comment on their involvement in this mechanism.
There is better evidence to implicate excitatory amino acids in the relay of estrogen's stimulatory influence on GnRH secretion at the time of the surge. The LH surge in rats is clearly blocked or attenuated by excitatory amino acid receptor antagonists, and this is not a pituitary effect (225) (226) (227) . Furthermore, glutamate and aspartate release within the vicinity of the GnRH cell bodies, but not the GnRH terminals, is seen to increase at the time of the surge (237-239). There is presently disagreement, however, as to the relative roles of estrogen and progesterone in the generation of this increased release (237-239). Nevertheless, it appears likely that the GnRH neurons, or cells in the vicinity of the preoptic area, are targets for increased excitatory amino acid release at the time of the surge and that estrogen is involved. By analogy with the magnocellular oxytocin network (240), excitatory amino acids may provide the excitatory signal responsible for initiating the GnRH surge.
The excitatory amino acids may also be involved in stim- (255) suggests that the preoptic GABA network of the rat is highly sensitive to circulating estrogens (250). Recent evidence also indicates a high level of ER expression in GABA neurons found within the vicinity of GnRH neurons in the pubertal monkey (256) . It is possible, therefore, that estrogen-sensitive GABA neurons have a role within the GnRH network in mediating part of the inhibitory effects of estrogen on GnRH neurons. Indeed, an inverse relationship exists between preoptic GABA levels and mean LH release in the rat; preoptic GABA release is low in ovariectomized rats that exhibit high LH output (251) and increased when estrogen exerts its inhibitory action on LH secretion (252, 253). A similar inverse profile of GABA levels and GnRH secretion has been detected in the prepubertal and pubertal monkey (248). Importantly, GABA A receptor blockade has been shown to elevate LH release in estrogen-treated rats (257) and anestrous sheep (247) exhibiting negative feedback. Together, these observations suggest that estrogen-receptive GABA neurons within the preoptic area, including the AVPv of the rat, may be partly responsible for mediating estrogen's inhibitory effects on GnRH secretion.
Another important observation has been that GABA concentrations within the vicinity of the GnRH cell bodies, but not GnRH terminals, fall before the onset of the LH/GnRH surge in the rat and sheep (238, 258, 259) . This is thought to be a prerequisite for the occurrence of the LH surge in the rat (246, 260). However, the relationship and mechanism of estrogen's influence, if any, on GABA neurons before the LH surge is less clear. Although estrogen does not influence the activity or mRNA expression of glutamic acid decarboxylase (the GABA synthetic enzyme) in the medial preoptic area of the rat (reviewed in Ref. 250), the decrease in GABA levels before the LH surge is known to correlate with a decrease in glutamic acid decarboxylase mRNA expression in neurons of this area (261, 262) . Recent studies suggest that this fall in glutamic acid decarboxylase mRNA expression results from the rise in progesterone secretion before the start of the LH surge (263) . Equally, however, the fall in GABA concentrations within the vicinity of the GnRH cell bodies may result from circadian inputs within the GnRH network in the rat. One further influence of estrogen within the preoptic GABA 260, 265) , but this looks to be a multifactorial response to estrogen, progesterone, and, possibly, circadian influences in the rat. The actions of GABA on GnRH neurons may not be restricted solely to the regulation of GnRH secretion, as recent studies have documented effects of pharmacological GABA receptor activation and blockade on GnRH mRNA expression in the female rat (266 -268) . The reported effects have not, however, been consistent. In the ovariectomized rat, GABA A receptor activation was found to have either no effect (266) or to decrease (268) GnRH mRNA content while GABA B receptor activation was also shown to have no effect (268) or to decrease (266) GnRH transcript levels. Hence, at this stage, it is not possible to determine whether the inhibitory effect of estrogen on GnRH mRNA content, suggested to be mediated by the AVPv (Section III.B), involves preoptic GABA projections to the GnRH neurons.
Neuropeptide Y (NPY).
NPY acts at the level of the GnRH cell bodies and terminals as well as at the gonadotrophs of the pituitary gland and has a clear role in facilitating both GnRH release and gonadotroph responsiveness to GnRH at the time of the LH surge (19, 20). The NPY innervation of the hypothalamus and preoptic area originates from essentially two cell populations, one located in the arcuate nucleus and the other in the brainstem (269, 270) . In terms of mediating estrogen's influence within the GnRH network, it is the NPY neurons located in the arcuate nucleus that are most likely to be regulated in a classic genomic manner by estrogen. Approximately 10% of NPY neurons in the arcuate nucleus express ERs in the rat (19) and sheep (220) , and NPY mRNA expression in this region is increased by estradiol (271) and elevated during proestrus (272) . In contrast, the NPY-containing neurons of the brainstem have not been found to express ER␣ immunoreactivity (273) .
Most evidence indicates that the median eminence is the principal site at which estrogen induces the stimulatory effect of NPY on GnRH neurons. In association with estrogen's enhancement of NPY mRNA expression in the arcuate nucleus (271) , an increase in NPY content (19) and release (274) is observed in the median eminence before and during the GnRH/LH surge of the rat. Further, NPY stimulates GnRH release from the median eminence, and this response has been shown to be potentiated by estrogen (275) and maximal at proestrus in rats (276) . A similar role for NPY in influencing GnRH release has been established in the primate (277, 278) and may also exist in the ewe (279) . In the rat, the NPY responses of GnRH terminals and gonadotrophs appear to be initiated by estrogen and then enhanced further by progesterone secreted in advance of the LH surge (19, 280, 281) . Hence, it seems not unreasonable to suggest that part of the facilitatory influence of estrogen on GnRH neurons at the time of the surge occurs through an elevation of NPY synthesis and secretion in the median eminence in addition to a likely sensitization of GnRH terminals to the stimulatory action of NPY.
The mechanisms underlying the effects of estrogen on the NPY receptors are unclear as ligand binding to the NPY Y1 receptor in the hypothalamus, which mediates the effects of NPY on GnRH release (19, 20), was shown recently to be unaffected by estrogen or progesterone administration (282) . Furthermore, it is not known whether GnRH neurons express the Y1 receptor. Although a direct effect of estrogen on the ER-expressing NPY cells of the arcuate nucleus seems likely to be involved in elevating NPY release in the median eminence, estrogen may also act indirectly by reducing opioid inhibition of these cells before the surge (283) .
Actions of NPY on the GnRH network outside the median eminence are also likely to exist but their physiological relevance is less clearly understood. Nerve terminals containing NPY have been found to synapse on GnRH cell bodies in the rat (284) and sheep (285), but not the monkey (286) , and NPY concentrations within the vicinity of the GnRH cell bodies increase on proestrus (287) and during the estradiol-induced LH surge in the rat (288) . Recent observations using retrograde tracing techniques indicate that NPY inputs to the immediate vicinity of the GnRH cell bodies in the rostral preoptic area come from neurons located in both the brainstem and arcuate nucleus and that a small number of the arcuate NPY neurons contain ER␣ (A. E. Herbison and S. X. Simonian, unpublished data). However, the effects of this potential estrogen-dependent increase in NPY input to the GnRH cell bodies are unknown. Data in the male rat suggest a role for NPY in regulating GnRH gene expression (289) .
Overall, however, the prime importance of the AVPv in mediating estrogen's stimulatory input within the GnRH network of the rat (Section III.A.1) should be borne in mind. The placement of estrogen implants in the arcuate nucleus is insufficient to generate an LH surge whereas implants in the preoptic area alone create a normal estrogen-induced surge (144, 145). Hence, in this light, the NPY neurons of the arcuate nucleus would seem very unlikely to provide all of the stimulatory gonadal steroid input required by the GnRH neurons to induce a surge. The AVPv is known to project massively to the arcuate nucleus (157), and it is possible that the AVPv coordinates the estrogen signal within the GnRH network by recruiting different components of the network such as, in this case, the arcuate NPY neurons to modulate secretion from the GnRH terminals and pituitary gonadotrophs.
Neurotensin.
A role for NT as a stimulatory input to the GnRH network has evolved through a series of studies that have shown that NT acts within the vicinity of the GnRH cell bodies to regulate the magnitude of the LH surge. The infusion of NT into the preoptic area increases the height of the LH surge (290, 291) while the administration of NT antisera reduces the size of the LH surge (292) . As neither treatment influences the timing of the LH surge, and there is no evidence for NT to modulate gonadotroph functioning (293) , NT neurons represent a stimulatory component of the GnRH network that may be independent of the circadian trigger in the rat.
Although the preoptic area has been defined as the site of NT's stimulatory influence within the GnRH network of the (300) . Many of these neurons coexpress dopamine and project to the median eminence (301, 302) from where NT release has been shown to be regulated by estrogen (303) . A role has been proposed for estrogendependent NT release from the median eminence in regulating PRL secretion while its involvement within the GnRH network is unknown (293).
6. Norepinephrine. NE is likely to exert a permissive influence favoring high output states of the GnRH neuron within the GnRH network (Ref. 201 for recent review) and several studies have suggested that the brainstem NE neurons play a role in mediating part of estrogen's stimulatory actions within the GnRH network. A good correlation exists between estradiol status and NE turnover or release in the preoptic area and median eminence (304 -310) , and NE concentrations in these areas are elevated before, or in association with, the occurrence of the LH surge (304, (307) (308) (309) (310) . Further, the acute effect of noradrenergic pathway ablation (311-313) or administration of ␣-adrenergic receptor antagonists is to block the occurrence of the LH surge (314 -316) .
An important observation in the NE ablation studies has been that the LH surge mechanism can exhibit full recovery several weeks after the lesioning (311, 312) . As suggested by a number of investigators and argued again recently (201) , this is good evidence for the permissive nature of NE within the GnRH network. It should not be regarded as a conventional inhibitory or excitatory drive, but rather as a neuromodulator that enables interactions within the network depending upon its local concentrations. Hence, as a part of the GnRH network that is not involved directly in determining the mode of GnRH output (201), NE's permissive actions should be theoretically replaceable under pathological conditions such as brain lesioning when a degree of neuronal plasticity may be evident. Equally, however, by acting as a permissive global influence under normal physiological conditions, the NE component of the network would represent a particularly effective manner through which estrogen could facilitate the output of the GnRH neurons.
Recent investigations have begun to establish the precise NE pathways through which estrogen influences the GnRH network. A number of experimental approaches in the rat have provided evidence of projections from NE neurons to the preoptic area (317) (318) (319) (320) (321) , and, more recently, Wright and Jennes (322) demonstrated that NE neurons in both the ventrolateral medulla (A1 neurons) and nucleus tractus solitarii (A2 neurons) project to the vicinity of the GnRH cell bodies. Subpopulations of these brainstem A1 and A2 neurons express ER␣ in the rat (273, 323) , and triple-labeling studies have now gone on to show that ERs are located in A2, but not A1, neurons which project to the immediate vicinity of rostral preoptic GnRH neurons in the rat (201) . Although the pattern of ER␣ expression in A1 and A2 neurons of the sheep is very similar to that of the rat (324), the estrogen-receptive NE inputs in this species may be different as there is relatively little evidence for A2 projections to the preoptic area in the ovine brain (325) .
Although the exact relationship of A1 and A2 inputs to GnRH neurons remains uncertain, they are likely to involve both direct and indirect actions. Electron microscopic investigations have found nerve terminals containing tyrosine hydroxylase synapsing on GnRH cell bodies (326, 327) , but no studies have demonstrated positively that these inputs contain NE rather than dopamine (127). Nevertheless, a recent investigation has reported the presence of ␣ 2A -adrenergic receptor immunoreactivity in native GnRH neurons (328) , and this indicates that NE neurons may form direct synapses with GnRH cells. It should be noted, however, that the stimulatory influence of NE within the GnRH network is mediated by ␣ 1 -adrenergic receptors (61, 315, 316, 329). Evidence for the indirect regulation of GnRH neurons by NE also exists and may involve, at least, a serial arrangement between NE, GABA, and GnRH neurons in the rat (264, 326, 330) . The location and exact targets of NE neurons that may influence GnRH secretion at the level of the nerve terminals within the median eminence are unknown (331) .
The precise manner in which estrogen influences NE neurons is not yet established. Estrogen has been demonstrated to increase the electrical excitability of NE neurons projecting to the preoptic area (332) and also to stimulate Fos (333) and tyrosine hydroxylase (334) gene expression in A2 neurons. Furthermore, the number of A2 neurons expressing Fos increases on proestrus before the onset of the LH surge (333, 335) . Hence, estrogen may facilitate a diurnal pattern of NE secretion within the preoptic area by stimulating the A2 subpopulation to elevate NE release in the morning/early afternoon of proestrus (307, 335) . In addition, there is good evidence for a presynaptic inhibition of NE release by ␤END in the preoptic area of the rat, and an estrogen-induced decrease in this tonic input may further contribute to the elevation of preoptic NE concentrations at the time of the LH surge (336 -339) . Together, these data indicate that the A2 neurons projecting to the immediate vicinity of the GnRH cell bodies are likely to be stimulated directly by estrogen and that, in association with a reduced presynaptic opioid re- straint, are responsible for the increased NE release within the rostral preoptic area. Much less is known about the gonadal steroid-induced changes in NE release within the median eminence, although it is notable that turnover in this region seems to be particularly sensitive to changes in serum progesterone concentrations (305) . Estrogen also alters adrenergic receptor expression and functioning within the preoptic area and hypothalamus. It has been shown to exert a relatively selective stimulatory influence upon the ␣ 1B adrenergic receptor subtype (340) , and studies have reported that estrogen enhances ␣ 1b adrenoceptor mRNA (341) to increase the density of these receptors within the preoptic area and hypothalamus. This is thought to be involved in the estrogenic modulation of second messenger pathways in these cells (197, 342) . Also, the electrical responses of neurons located in the arcuate nucleus to ␣-adrenergic agonists are enhanced by estrogen treatment (343) . How these receptor changes relate to alterations in the activity of the GnRH network is not clear. There is longstanding evidence for NE exerting inhibitory effects on LH secretion in ovariectomized animals and stimulatory actions on LH release in estrogen-treated rats (344 -346) . However, this exact "inhibition-stimulation" phenomenon has now been observed in response to many different neurotransmitters and neuropeptides (19, 223). As such, it is possible that the phenomenon does not result from any unique attribute of the individual neurochemical but, rather, represents gonadal steroid-dependent differences in the underlying properties and behavior of the GnRH neurons themselves and/or their most important primary afferents.
The estrogen-dependent increase in NE release upon cells of the preoptic area and median eminence in proestrous rats is likely to alter both GnRH secretion and biosynthesis. Although much evidence indicates that NE promotes GnRH secretion, the cellular mechanisms through which this may occur are not well established. Work in the male rat has suggested that NE stimulates GnRH secretion within the median eminence by inducing the synthesis of nitric oxide and prostaglandin E 2 (347) (348) (349) . Elsewhere in the brain, studies suggest that NE may facilitate electrical activity within a network by increasing the signal-to-noise ratio of specific synapses and even act as a 'gate' to enable silent excitatory inputs to function (350) . Such electrophysiological actions would be in good agreement with the proposed permissive influence of NE within the GnRH network where it may function to "enable" neurotransmission between components.
In terms of the potential for NE to influence GnRH mRNA expression, it is worth noting that the increase in NE concentrations within the vicinity of the GnRH cell bodies occurs before the onset of the LH surge (307, 308, 310) . Importantly, the estrogen-induced increase in GnRH mRNA content in rostral preoptic neurons is blocked by pretreatment with an ␣ 1 -adrenergic receptor antagonist (61). As cellular GnRH mRNA content can be elevated as little as 1 h after intraventricular NE administration (351) , the endogenous NE increase in the preoptic area on proestrus appears well positioned in a temporal sense to aid in the increased expression of GnRH mRNA, which occurs before the onset of the LH surge (53, 62). However, it is unclear at present whether this rapid NE-induced elevation in cellular GnRH mRNA content results from an increase in GnRH gene transcription, which is the principal mode of estrogen action upon GnRH mRNA content at this time (63, 64).
Opioid peptides.
Although substantial populations of enkephalin-and dynorphin-containing cell populations exist within the mediobasal hypothalamus and preoptic area, and some of these are regulated by gonadal steroids (166, 352, 353) , there is little work indicating whether they may be involved in transmitting estrogen input within the GnRH network. In the ovariectomized rat, dynorphins were shown to suppress LH release by acting through -opiate receptors while met-enkephalin exerted the same action via ␦-receptors (354, 355) . Light microscope immunocytochemical studies have shown enkephalin-and dynorphin-containing fibers in the vicinity of the GnRH cell bodies and terminals in the female rat (356) . However, studies examining the involvement of -and/or ␦-opiate receptors in mediating estrogen's inhibitory and stimulatory effects on LH secretion have not been undertaken (19).
In contrast, a substantial literature has built up around the role of ␤END and -opiate receptors within the GnRH network and their role in transmitting estrogen input. Neurons synthesizing ␤END are found exclusively within the region of the arcuate nucleus, and a small percentage (5-10%) have been shown to concentrate estradiol (357, 358) and express immunoreactive ER␣ in the rodent (D. P. Spratt and A. E.
Herbison, unpublished) and sheep (181). The likelihood of direct transsynaptic regulation of the GnRH neurons by
␤END is supported by the demonstration of ␤END-containing terminals synapsing on the dendrites and soma of GnRH neurons in the female rat (43, 359) and monkey (360) and direct actions of a -opiate receptor agonist on the electrical activity of GnRH neurons in the guinea pig (85). These observations are thought to be functionally relevant as infusions of -opiate receptor agonists or antagonists into the preoptic area alter LH release in vivo (361) (362) (363) . However, the recent finding that -, ␦-, and -opiate receptor mRNAs are all detectable within rostral preoptic area cells but not GnRH neurons, when assessed using dual labeling in situ hybridization (364) , has questioned whether ␤END may, indeed, be acting directly upon GnRH neurons. Certainly, evidence exists for both NE (19, 338) and excitatory amino acids (365) as mediators of opioid peptide influences on LH secretion. Further, some pharmacological data suggest that opioid peptides may act within the mediobasal hypothalamus to influence GnRH secretion (361, 366) . Hence, the ␤END neurons are most likely to exert both direct and indirect actions on GnRH neurons within the network.
Brain lesion and implant studies suggest that neurons located in the arcuate nucleus may represent one pathway through which the inhibitory influence of estrogen is exerted on GnRH secretion (Section III.B). The potent inhibitory actions of ␤END and -opiate receptor agonists upon LH release in ovariectomized rats and the ability of naloxone, an opiate receptor antagonist, to elevate the low level of LH secretion observed in the presence of estrogen (354, 355, 362, 367, 368) suggested that the arcuate ␤END neurons may subserve just such a role. However, subsequent studies re-
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ESTROGEN INPUTS TO GnRH NEURONSvealed that naloxone stimulated GnRH and LH secretion in a manner that was independent of gonadal steroid status in rats as well as ewes (369 -371) . Hence, despite early promise, the ␤END neurons have now been shown not to mediate estrogen's inhibitory influence on GnRH secretion. Rather, the naloxone data indicate that the ␤END neurons form a component of the GnRH network that maintains a continuous inhibitory tone within the network and that this may be involved in determining the dynamics of individual GnRH pulses (371) . There is, nevertheless, an important role proposed for ␤END in mediating some of the stimulatory effects of estrogen on GnRH neurons in rats, sheep, and primates (19, 372) . Consistent results from several laboratories have shown that a substantial reduction in opioid activity occurs within the GnRH network preceding the LH surge. Whereas naloxone administration reveals a tonic inhibitory opioid tone at other times of the ovarian cycle, it fails to alter LH secretion when administered in the afternoon before the natural or estrogen-induced surge commences (373) (374) (375) . This, along with data showing a reduction in ␤END peptide content in the preoptic area and mediobasal hypothalamus of rats and sheep (372) and a fall in ␤END release from the median eminence on proestrus (376) , indicates that a reduction in ␤END release occurs within the GnRH network before the LH surge occurs. Changes are also evident in -opiate receptor function as, unlike other times of the cycle, morphine exerts no effects upon LH secretion when administered before the surge (368) . Furthermore, a fall in naloxone binding occurs on the afternoon of the LH surge in the preoptic area and median eminence (377, 378) . Together these observations indicate that a relatively brief period of reduced ␤END release and -opiate receptor activity occurs at the time of the LH surge to dis-inhibit the GnRH network.
Estrogen has an important role in bringing about this presurge dis-inhibition by decreasing both opioid receptor binding (379) and ␤END release (372, 380 -384) . In terms of the latter, it is clear that prolonged estrogen exposure decreases ␤END mRNA and peptide expression within the arcuate nucleus (380, 382, 383) . However, ␤END peptide and mRNA analyses also show that a significant diurnal rhythm occurs within the ␤END neurons; ␤END expression is lowest in the afternoon, and this diurnal rhythm is only evident in the presence of estrogen (381, 384, 385) . Hence, the arcuate ␤END neurons may be an additional site at which estrogen and circadian inputs are integrated before transmission to the GnRH neurons in the rat. Such an hypothesis is in agreement with experiments that have shown that the artificial reduction of opiate activity on the afternoon of proestrus can advance the onset of the LH surge (386 -388) . Thus, it seems that one of the mechanisms underlying the stimulatory influence of estrogen upon GnRH secretion is to enable ␤END neurons to exhibit a diurnal decline in their level of biosynthetic and secretory activity and, like the preoptic GABA neurons, dis-inhibit the GnRH neurons at the time of the surge.
As with a number of other estrogen-induced processes at the time of the LH surge in the rat (19), progesterone facilitates the effects of estrogen and initially promotes the afternoon decline in ␤END activity within the GnRH network (19, 386, 388, 389) . However, the marked increase in progesterone concentrations that follows the onset of the LH surge exerts an opposite effect to estrogen on these cells and increases ␤END mRNA levels (381, 383) . This is suggested to be the neural mechanism through which progesterone inhibits the occurrence of a further estrogen-induced LH surge on estrus (386, 389) . Progesterone has similarly been suggested to utilize ␤END neurons to inhibit LH secretion in the sheep (4).
The neural pathways through which circadian and estrogen inputs regulate the ␤END neurons to influence GnRH neurons in the rat are not entirely clear. Neural inputs from the suprachiasmatic nucleus to the arcuate are known in the rat (390 -392) and may well underlie the diurnal activity of these neurons. It is more difficult, however, to envisage how estrogen exerts its genomic influence upon this cell population as only approximately 5% of these cells concentrate estradiol (357) or express immunocytochemically detectable ER␣ (D. P. Spratt and A. E. Herbison, unpublished), and ER␤ is not reported to be in abundance within the arcuate nucleus of the rat (155, 156). Hence, estrogen may regulate the gene expression and secretory activity of ␤END neurons through mechanisms that are indirect. This issue is emphasized further by our recent unpublished observation that none of the arcuate ␤END neurons projecting to the immediate vicinity of rostral preoptic area GnRH neurons express ER␣ immunoreactivity. Yet again, it is worth emphasizing that the arcuate nucleus is insufficient on its own to mediate the stimulatory effects of estrogen within the GnRH network (Section III.A). Hence, as suggested for NPY, it may be that the estrogen-receptive neurons of the AVPv have a role in transsynaptically influencing the activity of the arcuate ␤END neurons. As highlighted above, the precise nature of ␤END interactions with GnRH neurons is unclear.
C. Glial cells as intermediaries
There is growing support for an important structural and chemical interaction between glial cells and GnRH neurons (393). Glial cells surround GnRH cell bodies, and alterations in this ensheathment may underlie the associated changes in synaptic input to GnRH neurons reported after gonadal steroid manipulations (126). Equally, gonadal steroid-dependent alterations in the level of encasement of GnRH terminals by tanycytic end-feet could play an important role in regulating the dynamics of GnRH release into the portal vasculature (134). The lack of directly relevant data makes it difficult to ascribe a role for these structural alterations in either the inhibitory or stimulatory effects of estrogen within the GnRH network. However, it is pertinent that estrogen increases the growth and branching of glial cell processes (394, 395) and has been reported to exert relatively fast (5 h), reversible effects on the glial cell ensheathment of neurons in the arcuate nucleus (396). In this light, it would be very useful to know whether estrogen exerts similar effects on the GnRH-glial relationship.
The evidence for bidirectional influences of chemical messengers between glial cells and GnRH neurons arises almost entirely from in vitro studies using GnRH-secreting neuronal lines such as the GT1 cells (393 
D. Summary
Estrogen uses a variety of different mechanisms to regulate the biosynthetic and secretory activity of GnRH neurons (Table 2 ).
In terms of estrogen's stimulatory actions on GnRH neurons, there is good evidence for at least five different neurotransmitter pathways being involved in stimulating GnRH secretion at the time of the surge ( Fig. 3 and Table 2 ). The excitatory amino acids, NT and NE, are all used by estrogen to activate GnRH electrical activity at the level of the GnRH cell body, while NPY and NE have a similar role within the median eminence, presumably on GnRH terminals. Estrogen also utilizes the ␤END neurons but, in this case, reduces their level of activity to dis-inhibit GnRH neurons. It is less clear whether the GABA-ergic dis-inhibition, also occurring at this time, is driven primarily by estrogen. Hence, estrogen appears to orchestrate the activity patterns of several neurotransmitter systems within the GnRH network to bring about the GnRH surge. At present, there is little primary evidence for estrogen to activate GnRH neurons directly or alter glial cell interactions to elevate GnRH secretion ( Table 2 ). The one anomaly in this scenario is that the NT input is the only component that could be regarded as originating from the AVPv, the principal site at which estrogen is thought to act to initiate the GnRH surge in the rat. It is suggested that the very substantial projections from the AVPv to the arcuate nucleus may represent an important pathway through which estrogen coordinates NPY and ␤END neurons to help induce the surge. The NE component of the network should be regarded as a permissive neuromodulatory element. Quite clearly, each of these interconnected, yet parallel, components must be functional for the GnRH surge to occur; the acute pharmacological disruption of any one will prevent its occurrence. The prolonged period of estrogen exposure required for the GnRH surge to occur is entirely consistent with the generation by estrogen of a coordinated cascade of events mediated by ER-dependent alterations in gene transcription. In the rat, there is potential for the circadian and estrogen inputs to be integrated at the level of the ER-expressing AVPv neurons and/or the ␤END cells of the arcuate nucleus.
The pathways through which estrogen stimulates GnRH gene transcription before the onset of the surge in the rat are unknown. There remains no positive evidence for the expression of classical ERs in native GnRH neurons, and it is not clear whether the excitatory amino acids, NPY and/or NE, the three candidates shown to stimulate GnRH mRNA content, are able to increase GnRH gene transcription ( Table  2) . As a neuronal input originating from the preoptic area is implicated in increasing GnRH mRNA expression in response to estrogen, the critical neural population may not yet have been identified.
In terms of the inhibitory actions of estrogen on GnRH neurons, there is less solid evidence for the involvement of estrogen-receptive interneuron populations (Table 2) . Of all the neural populations reviewed, only GABA can be postulated to be involved in the inhibition of GnRH secretion, and ␤END has been positively excluded. This is despite the LH response to many different neurochemicals being inhibitory in the absence of estrogen and stimulatory in its presence. There is convincing evidence in the guinea pig that estrogen inhibits GnRH secretion through a direct membrane action. This observation is compatible with evidence that estradiol can inhibit LH secretion when placed in the immediate vicinity of the GnRH neurons and that estrogen exerts relatively rapid inhibitory effects on GnRH release. As altered ultrastructural glial-GnRH relationships are observed when comparing intact and gonadectomized animals, estrogen 
June, 1998
ESTROGEN INPUTS TO GnRH NEURONSmay also act at this level to inhibit activity within the GnRH network. Hence, present data indicate that estrogen may use multiple different modes of action to repress GnRH secretion into the portal circulation (Table 2) . There is almost no information available on the mechanisms through which estrogen may inhibit GnRH mRNA expression (Table 2 ).
V. Model of Estrogen Action on GnRH Neurons
The simplest model of estrogen action on GnRH neurons, which incorporates the features outlined above, is one in which independent pathways mediate the inhibitory and stimulatory influences of estrogen within the GnRH network (Fig. 4) . This is suggested by evidence of 1) different brain sites involved in bringing about the two modes of estrogen action, 2) different rates of estrogen's stimulatory and inhibitory influences, and 3) data indicating that the inhibitory and stimulatory actions can occur independently of one another (Section III.C).
In the proposed model, the inhibitory actions of estrogen would involve all three of the modes of estrogen input (direct, transsynaptic, and glial; Fig. 2 and Table 2 ) and are envisaged to occur through an initial rapid and direct hyperpolarization of GnRH neurons followed by an increase in preoptic GABA release from estrogen-sensitive interneurons within hours and then structural rearrangements in glial cell interactions with GnRH cell bodies and terminals over hours to days. As such, the inhibitory actions of estrogen would occur rapidly but ultimately involve several anatomically distinct components with differing temporal onset (and offset). It is of note that much difficulty has been experienced in identifying a single brain region mediating the inhibitory effects of estrogen on GnRH neurons (Section III.B) and that a considerable degree of fluctuation in GnRH output occurs with time after gonadectomy (see Ref. 51 ). Once established, the multimodal nature of the inhibitory input would suggest a relatively stable form of feedback on a day-to-day basis. Nevertheless, in situations such as the seasonally breeding ewe, where the sensitivity of the GnRH neurons to estrogen's inhibitory actions is clearly enhanced during the months of anestrus, new neural populations such as the A15 dopaminergic neurons may be recruited specifically at this time to enhance negative feedback actions of estrogen.
Hence, the proposed estrogen-sensitive inhibitory pathway would account for the relatively fast actions of estrogen in reducing GnRH secretion, the difficulties faced in trying to establish a single brain region mediating these actions, and the varying influence of time after ovariectomy on GnRH output. The ability to add and remove additional components to the pathway would enable the longer term modulation of estrogen's inhibitory influence within the network.
In contrast to the inhibitory pathway, the stimulatory effects of estrogen are proposed to be unimodal and involve principally the transsynaptic regulation of GnRH neurons by estrogen-sensitive neurons (Fig. 4) . At present there is good evidence for the involvement of several neurotransmitter populations in bringing about the stimulatory actions of es-
Neuronal cell populations within the GnRH network implicated in transmitting estrogen input to GnRH neurons in the rat. This may be direct or indirect on the GnRH neuron and involve cell body or terminal levels of regulation. Note that the neurochemical identity of estrogen-receptive neurons within the GnRH network is not fully established. Neurons with black nuclei express nuclear ERs. An estrogenreceptive neuronal population in the AVPv is hypothesized to project to, and coordinate, neuronal activity within the arcuate nucleus. 318 HERBISON Vol. 19, No. 3 trogen (Fig. 3) , but no data on rapid membrane actions and little direct evidence for ultrastructural glial-GnRH changes (Table 2) . Indeed, the recent evidence that elevated estrogen concentrations need not be present at the time of surge onset itself (106) suggests that direct rapid actions of estrogen on GnRH have no role at this time. The prolonged 15-h period of estrogen exposure required to generate the GnRH surge is entirely consistent with a classic genomic action of estrogen to alter gene expression and drive a cascade of temporally distinct but coordinated neurochemical activities at different levels within the GnRH network to alter gene expression. The increasing concentrations of estradiol before the surge would thus enhance the synthesis and release of stimulatory neurotransmitters such as the excitatory amino acids, NT, NPY, and NE, while decreasing the synthesis and release of inhibitory neurotransmitters such as ␤END, and possibly GABA. In rats, the circadian input within the GnRH network is only seen to involve estrogen's stimulatory aspects and would, as evidence suggests (Section IV.B), interact with neuronal populations implicated in the stimulatory pathway. The main feature of this model is that it does not rely on a "switch" from the so-called negative to positive feedback actions of estrogen. Instead, it is suggested that the stimulatory transsynaptic pathway is driven by the fluctuating estrogen concentrations and that this predominates over a relatively constant multimodal inhibitory pathway for a short period each cycle to evoke the GnRH surge (Fig. 4) . Hence, estrogen would use direct, transsynaptic, and glial cells' modes of action to establish a relatively restrained pattern of pulsatile GnRH secretion, and possibly GnRH biosynthesis, whereas the stimulatory effects of estrogen would result from the cyclical activation of specific neuronal cell populations, which would intermittently superimpose their influence upon GnRH secretion and biosynthesis to generate the GnRH surge. Data in both the rat (20) and sheep (10) would support the concept that a surge-specific pattern of GnRH secretion superimposes itself upon the normal pulsatile profile of GnRH release observed under estrogen's inhibitory influence. In the rat, estrogen-induced progesterone receptors, transactivated in a ligand-dependent or -independent manner (20), would appear to facilitate the effects of estrogen within the ER-expressing neuronal components of the GnRH network at the beginning of the surge. Thus, at any one time, it is proposed that the mode of GnRH secretion will reflect the net balance of estrogen-regulated inhibitory and stimulatory pathway influences within the GnRH network (Fig. 4) .
VI. Concluding Remarks
Much has yet to be done to establish the precise manner in which estrogen regulates GnRH neurons. As indicated, at least three different modes of estrogen action can participate in mediating estrogen's influence on GnRH neurons, and one of these implicates several distinct neurotransmitter systems. It is a substantial task to design and undertake experiments that will clearly establish which components are critical in mediating which actions of estrogen within the GnRH network. It is hoped that, despite the numerous species differences highlighted in this review, a core functional element of the GnRH network, based upon neurochemical phenotype rather than anatomical location, may become apparent in mammalian species. Certainly, there are a good number of It is suggested that a multimodal inhibitory pathway (net activity represented by the dashed line) involving direct nongenomic, estrogenregulated transsynaptic influences and glial cell ultrastructural rearrangements is used by estrogen to provide a restrained level of GnRH secretion compared with ovariectomized animals (shaded region to left). A unimodal stimulatory pathway (net activity represented by the thick line) involving classic genomic actions of estrogen on ER-containing neurons within the GnRH network is driven by fluctuating estrogen concentrations (bottom line). The stimulatory pathway superimposes its influence upon that of the inhibitory pathway so that, for a brief period each cycle (*), a net stimulatory influence evokes the GnRH surge.
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species similarities but, as with the differences, their relative importance has yet to be established. This review has focused on those pathways and neurochemicals clearly implicated in mediating estrogen's influence within the GnRH network but doubtless, further work will change this situation. It is expected that a concerted investigation of the AVPv region in the rat will enhance our understanding of estrogen's stimulatory influence on GnRH neurons. Similarly, substantial progress may result from furthering our understanding of the direct nongenomic influence of estrogen on GnRH neurons as well as the elucidation of interactions between glial cells and GnRH neurons. In the end, however, the inability to gather information directly from native GnRH neurons has been a substantial hindrance to progress in this field, and technological advances addressing this problem should be of great value to our further understanding of the GnRH neurons and the neural regulation of fertility. 
